Home » Topics » Bone Metabolism »
A major adverse effect of glucocorticoid treatment is significant bone loss, which is most pronounced in the first 3 to 6 months of use.
A potential association was found between ulcerative colitis and decreased bone mineral density, regardless of steroid exposure.
High-intensity progressive resistance and impact training is a well-tolerated program that may improve bone mineral density and physical function in older men.
In older women, the risk for major osteoporotic fracture is not associated with long-term inhaled corticosteroid use and consequent respiratory diseases.
The Osteogenesis Imperfecta and Childhood Osteoporosis Working Group of the Spanish Society of Pediatric Rheumatology developed guidelines for the prevention, diagnosis, and treatment of secondary childhood osteoporosis.
Treatment with proton pump inhibitors is associated with increased risk for osteoporotic fracture compared with the use of histamine-2 receptor antagonists.
Researchers determined whether a computer learning model could classify hand radiographs with osteoporosis based on the second metacarpal cortical percentage.
Incidence of osteoporosis is significantly increased in patients with inflammatory bowel disease.
Treatment with zoledronic acid may be associated with an increased risk for heart failure, fracture, and mortality compared with the use of oral bisphosphonates or no treatment.
Researchers assessed the effect of hyperuricemia with and without psoriasis on bone microstructure and volumetric bone mineral density.
Denosumab increases bone mineral density and decreases vertebral fracture risk in postmenopausal women with osteoporosis and diabetes.
Increased serum calcium levels are associated with a reduction in whole-body bone mineral density.
Want to read more?
Please login or register first to view this content.